Tissue microarray analysis reveals protein expression patterns and potential biomarkers of clinical benefit to bortezomib in relapsed/refractory non-Hodgkin lymphoma.
Br J Haematol
; 158(2): 290-292, 2012 Jul.
Article
in En
| MEDLINE
| ID: mdl-22533368
Full text:
1
Database:
MEDLINE
Main subject:
Pyrazines
/
Boronic Acids
/
Lymphoma, Non-Hodgkin
/
Biomarkers, Tumor
Type of study:
Clinical_trials
Limits:
Adult
/
Aged
/
Aged80
/
Humans
/
Middle aged
Language:
En
Journal:
Br J Haematol
Year:
2012
Type:
Article
Affiliation country:
United States